Allergists, ER Doctors Should Cooperate in Anaphylaxis Care

This article originally appeared here.
Share this content:
Allergists, ER Doctors Should Cooperate in Anaphylaxis Care
Allergists, ER Doctors Should Cooperate in Anaphylaxis Care

(HealthDay News) -- Allergists and emergency medicine physicians should continue to work together to improve anaphylaxis care, according to a review published online Aug. 6 in the Annals of Allergy, Asthma & Immunology.

Stanley M. Fineman, M.D., from the Emory University School of Medicine in Atlanta, and colleagues reviewed recent scientific literature relating to anaphylaxis, barriers to care, and improvement in emergency anaphylaxis care. An expert panel of allergists and emergency physicians was convened to discuss medical management of anaphylaxis across the continuum of care: from the emergency department through long-term care.

Difficulties in making an accurate diagnosis, low rates of epinephrine administration during acute management, and inadequate follow-up were identified by the panel as key barriers to anaphylaxis care. They emphasized that epinephrine should be used as the first-line therapy for those with anaphylaxis or at risk for anaphylaxis and for those with severe allergic reactions; when in doubt, epinephrine should be administered. The panel discussed strategies to overcome the barriers identified and made recommendations for future allergist/emergency physician collaboration. They also proposed key messages to be communicated to emergency practitioners.

"The panel recommended that allergists and emergency physicians continue to work in partnership, that allergists be proactive in outreach to emergency care practitioners, and that easy-to-access educational programs and materials be developed for use by emergency medical systems and emergency department practitioners in the training environment and in practice," the authors write.

The study was funded by an educational grant from Mylan Specialty.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

ASTRO: No Survival Benefit for Adding EBT to Brachytherapy

ASTRO: No Survival Benefit for Adding EBT to ...

Addition of external beam therapy doesn't improve five-year progression-free survival in prostate cancer

ASTRO: Fewer Side Effects With IMRT in Cervical, Endometrial CA

ASTRO: Fewer Side Effects With IMRT in Cervical, ...

Patients in conventional radiotherapy arm had more high-level adverse events than those in IMRT arm

Many Doctors Reluctant to Reveal Mental Health Issues

Many Doctors Reluctant to Reveal Mental Health Issues

Perceived stigma, fear of career repercussions hinder treatment, study suggests

is free, fast, and customized just for you!

Already a member?

Sign In Now »